BioNTech and Pfizer's coronavirus vaccine shows potential in human trial
July 01, 2020 at 09:36 AM EDT
A COVID-19 vaccine developed by German biotech firm BioNTech and U.S. pharmaceutical giant Pfizer has shown potential and was found to be well tolerated in early-stage human trials, the companies said on Wednesday.
